This study is in progress, not accepting new patients
A Study With Imlifidase in Anti-GBM Disease
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Suphamai Bunnapradist, MD, MS (ucla)

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Suphamai Bunnapradist, MD, MS (ucla)
Professor of Clinical, Medicine. Authored (or co-authored) 218 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hansa Biopharma AB
- ID
- NCT05679401
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 50 study participants
- Last Updated